The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available, the Nine-Hole Peg Test (NHPT) is considered as a gold standard measure o...
Gespeichert in:
| Veröffentlicht in: | Multiple sclerosis Jg. 23; H. 5; S. 711 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
01.04.2017
|
| Schlagworte: | |
| ISSN: | 1477-0970, 1477-0970 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available, the Nine-Hole Peg Test (NHPT) is considered as a gold standard measure of manual dexterity and most frequently used in MS research and clinical practice. The MS Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with MS. Among the MSOAC goals are acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful to persons with MS. A critical step for these neuroperformance metrics is elucidation of clinically relevant benchmarks, well-defined degrees of disability, and gradients of change that are deemed clinically meaningful. This article addresses the NHPT, the proposed MSOAC measure for upper extremity function. We find that the NHPT is reliable within and between test sessions, discriminates between healthy subjects and MS patients with different levels of upper limb impairment, and shows high convergent validity with other manual dexterity as well as more comprehensive upper limb measures. Ecological validity is established by its relation to perceived upper limb use in daily life and perceived difficulty in performing activities of daily living. The NHPT is responsive to deterioration in longitudinal studies, and research suggests that a 20% change in test score is commonly used to define clinically meaningful worsening, a definition that needs further validation in all stages of the disease. |
|---|---|
| AbstractList | Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available, the Nine-Hole Peg Test (NHPT) is considered as a gold standard measure of manual dexterity and most frequently used in MS research and clinical practice. The MS Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with MS. Among the MSOAC goals are acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful to persons with MS. A critical step for these neuroperformance metrics is elucidation of clinically relevant benchmarks, well-defined degrees of disability, and gradients of change that are deemed clinically meaningful. This article addresses the NHPT, the proposed MSOAC measure for upper extremity function. We find that the NHPT is reliable within and between test sessions, discriminates between healthy subjects and MS patients with different levels of upper limb impairment, and shows high convergent validity with other manual dexterity as well as more comprehensive upper limb measures. Ecological validity is established by its relation to perceived upper limb use in daily life and perceived difficulty in performing activities of daily living. The NHPT is responsive to deterioration in longitudinal studies, and research suggests that a 20% change in test score is commonly used to define clinically meaningful worsening, a definition that needs further validation in all stages of the disease.Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available, the Nine-Hole Peg Test (NHPT) is considered as a gold standard measure of manual dexterity and most frequently used in MS research and clinical practice. The MS Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with MS. Among the MSOAC goals are acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful to persons with MS. A critical step for these neuroperformance metrics is elucidation of clinically relevant benchmarks, well-defined degrees of disability, and gradients of change that are deemed clinically meaningful. This article addresses the NHPT, the proposed MSOAC measure for upper extremity function. We find that the NHPT is reliable within and between test sessions, discriminates between healthy subjects and MS patients with different levels of upper limb impairment, and shows high convergent validity with other manual dexterity as well as more comprehensive upper limb measures. Ecological validity is established by its relation to perceived upper limb use in daily life and perceived difficulty in performing activities of daily living. The NHPT is responsive to deterioration in longitudinal studies, and research suggests that a 20% change in test score is commonly used to define clinically meaningful worsening, a definition that needs further validation in all stages of the disease. Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available, the Nine-Hole Peg Test (NHPT) is considered as a gold standard measure of manual dexterity and most frequently used in MS research and clinical practice. The MS Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with MS. Among the MSOAC goals are acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful to persons with MS. A critical step for these neuroperformance metrics is elucidation of clinically relevant benchmarks, well-defined degrees of disability, and gradients of change that are deemed clinically meaningful. This article addresses the NHPT, the proposed MSOAC measure for upper extremity function. We find that the NHPT is reliable within and between test sessions, discriminates between healthy subjects and MS patients with different levels of upper limb impairment, and shows high convergent validity with other manual dexterity as well as more comprehensive upper limb measures. Ecological validity is established by its relation to perceived upper limb use in daily life and perceived difficulty in performing activities of daily living. The NHPT is responsive to deterioration in longitudinal studies, and research suggests that a 20% change in test score is commonly used to define clinically meaningful worsening, a definition that needs further validation in all stages of the disease. |
| Author | Lamers, Ilse Francis, Gordon LaRocca, Nicholas Phillips, Glenn Benedict, Ralph Feys, Peter Hudson, Lynn D Rudick, Richard |
| AuthorAffiliation | Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA |
| AuthorAffiliation_xml | – name: Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA |
| Author_xml | – sequence: 1 givenname: Peter surname: Feys fullname: Feys, Peter organization: Rehabilitation Research Center (REVAL), Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium – sequence: 2 givenname: Ilse surname: Lamers fullname: Lamers, Ilse organization: Rehabilitation Research Center (REVAL), Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium – sequence: 3 givenname: Gordon surname: Francis fullname: Francis, Gordon organization: Neuroscience Clinical Development, San Francisco, CA, USA – sequence: 4 givenname: Ralph surname: Benedict fullname: Benedict, Ralph organization: Department of Neurology, University at Buffalo, Buffalo, NY, USA – sequence: 5 givenname: Glenn surname: Phillips fullname: Phillips, Glenn organization: Biogen, Cambridge, MA, USA – sequence: 6 givenname: Nicholas surname: LaRocca fullname: LaRocca, Nicholas organization: National Multiple Sclerosis Society, New York, NY, USA – sequence: 7 givenname: Lynn D surname: Hudson fullname: Hudson, Lynn D organization: Critical Path Institute, Tucson, AZ, USA – sequence: 8 givenname: Richard surname: Rudick fullname: Rudick, Richard organization: Biogen, Cambridge, MA, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28206826$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE1LxDAQhoOsuB969yQ5eqlO0qRJjrK4rrCohxWPJU2nWumXSQvuvzfgCp5meHneYXiWZNb1HRJyyeCGMaVuWSq5kFoylRnQXJyQBRNKJWAUzP7tc7IM4RMAlErlGZlzzSHTPFuQt_0H0qe6w2TbN0hf8J3uMYzUBmppa7vJNrTE7xF9PR7ogL7qfYwd0hZtmDzSGNB2asZ6iP3gGvR9qMM5Oa1sE_DiOFfkdXO_X2-T3fPD4_pulzhp9JgYBHBOVEowlMwUUgpXujJTxtiq5EYUmqXAFBinI6AtY7LCNCvB8BIKwVfk-vfu4PuvKX6et3Vw2DS2w34KOdPRTDRgIKJXR3QqWizzwdet9Yf8Twb_Ac3qYms |
| CitedBy_id | crossref_primary_10_1177_13524585241260145 crossref_primary_10_1007_s00415_017_8676_8 crossref_primary_10_7224_1537_2073_2021_069 crossref_primary_10_1016_j_msard_2022_104455 crossref_primary_10_1177_17562864211057661 crossref_primary_10_7759_cureus_74001 crossref_primary_10_23736_S1973_9087_20_06446_1 crossref_primary_10_3390_medicina61010070 crossref_primary_10_2196_37614 crossref_primary_10_1002_mus_26836 crossref_primary_10_1177_1352458518779952 crossref_primary_10_33808_clinexphealthsci_809605 crossref_primary_10_1016_j_msard_2022_103917 crossref_primary_10_1080_09638288_2024_2415328 crossref_primary_10_1212_WNL_0000000000213558 crossref_primary_10_1177_13524585221114997 crossref_primary_10_1016_j_neuroimage_2023_120348 crossref_primary_10_1007_s00415_022_11124_9 crossref_primary_10_1016_j_msard_2021_103081 crossref_primary_10_1177_1352458519876701 crossref_primary_10_1002_acn3_51996 crossref_primary_10_1080_08990220_2020_1753685 crossref_primary_10_1007_s12311_022_01435_y crossref_primary_10_1007_s12975_019_00724_9 crossref_primary_10_3389_fneur_2020_00700 crossref_primary_10_3389_fneur_2018_00718 crossref_primary_10_1016_j_nicl_2023_103529 crossref_primary_10_3390_jcm12134549 crossref_primary_10_1177_1352458517690825 crossref_primary_10_3390_brainsci15090945 crossref_primary_10_1044_2018_AJA_17_0118 crossref_primary_10_1111_ene_14059 crossref_primary_10_3389_fresc_2022_997221 crossref_primary_10_1177_1352458520958356 crossref_primary_10_1186_s42466_022_00219_3 crossref_primary_10_34172_PS_025_41013 crossref_primary_10_1007_s12035_023_03778_x crossref_primary_10_3389_fneur_2021_608491 crossref_primary_10_1007_s00415_022_11114_x crossref_primary_10_1161_STROKEAHA_118_022706 crossref_primary_10_1089_brain_2019_0726 crossref_primary_10_1016_j_msard_2022_104433 crossref_primary_10_1007_s12325_019_00958_x crossref_primary_10_1007_s10072_020_04263_2 crossref_primary_10_1097_MRR_0000000000000362 crossref_primary_10_3390_diagnostics15070936 crossref_primary_10_1016_j_clinph_2024_09_003 crossref_primary_10_1016_j_neurol_2023_03_010 crossref_primary_10_1111_ene_15162 crossref_primary_10_1111_ene_15163 crossref_primary_10_3390_jcm11154401 crossref_primary_10_1007_s40265_021_01526_w crossref_primary_10_3390_brainsci15080807 crossref_primary_10_1136_bmjopen_2018_025932 crossref_primary_10_1177_09636897241233045 crossref_primary_10_1007_s13760_023_02172_7 crossref_primary_10_1016_j_msard_2025_106375 crossref_primary_10_1136_jmedgenet_2021_107954 crossref_primary_10_1016_j_jocn_2020_10_034 crossref_primary_10_1016_j_neuroscience_2019_05_004 crossref_primary_10_1109_ACCESS_2023_3311270 crossref_primary_10_3390_cells14130969 crossref_primary_10_3390_biom11091342 crossref_primary_10_3390_brainsci10030185 crossref_primary_10_1016_j_msard_2019_06_014 crossref_primary_10_3389_fneur_2023_1172419 crossref_primary_10_52881_gsbdergi_1762684 crossref_primary_10_3390_neurolint17080118 crossref_primary_10_1038_s41598_025_07429_0 crossref_primary_10_1177_13524585251364720 crossref_primary_10_1111_ene_15289 crossref_primary_10_1007_s40273_020_00964_w crossref_primary_10_1177_13524585211018103 crossref_primary_10_1016_j_jelekin_2021_102607 crossref_primary_10_1016_j_jns_2024_123068 crossref_primary_10_1016_j_nicl_2021_102653 crossref_primary_10_3389_fpsyg_2025_1620235 crossref_primary_10_1007_s40846_025_00980_1 crossref_primary_10_1186_s12984_024_01413_x crossref_primary_10_1177_13524585231187283 crossref_primary_10_23736_S1973_9087_21_06689_2 crossref_primary_10_1177_1352458517723718 crossref_primary_10_1016_j_msard_2025_106265 crossref_primary_10_5812_mejrh_64343 crossref_primary_10_1093_brain_awac203 crossref_primary_10_1111_ane_13313 crossref_primary_10_3390_cells8111439 crossref_primary_10_3390_healthcare12050550 crossref_primary_10_1016_j_rehab_2021_101625 crossref_primary_10_1186_s12883_019_1421_4 crossref_primary_10_1007_s40263_024_01132_w crossref_primary_10_1016_j_msard_2021_103165 crossref_primary_10_1177_13524585221094224 crossref_primary_10_1080_10543406_2023_2280557 crossref_primary_10_1186_s13049_021_00990_3 crossref_primary_10_1007_s00415_024_12648_y crossref_primary_10_1111_cns_70547 crossref_primary_10_1016_j_clineuro_2024_108165 crossref_primary_10_1155_2021_5583063 crossref_primary_10_1016_j_msard_2022_103725 crossref_primary_10_1177_2055217321989384 crossref_primary_10_7224_1537_2073_2022_104 crossref_primary_10_1097_PEP_0000000000000903 crossref_primary_10_1177_1352458520987539 crossref_primary_10_1007_s00415_017_8690_x crossref_primary_10_3389_fneur_2021_758710 crossref_primary_10_1016_j_msard_2025_106271 crossref_primary_10_1007_s10072_022_06456_3 crossref_primary_10_1371_journal_pone_0262480 crossref_primary_10_3233_NRE_203029 crossref_primary_10_1002_ana_26239 crossref_primary_10_1016_j_nerep_2022_100101 crossref_primary_10_1109_TNSRE_2025_3576669 crossref_primary_10_3390_children10030559 crossref_primary_10_1016_j_msard_2019_101411 crossref_primary_10_3389_fneur_2020_00900 crossref_primary_10_1016_j_cct_2024_107544 crossref_primary_10_1016_j_msard_2022_104004 crossref_primary_10_1080_14737175_2025_2450788 crossref_primary_10_36425_rehab625507 crossref_primary_10_1111_ene_15220 crossref_primary_10_1080_08990220_2019_1644998 crossref_primary_10_1007_s00431_022_04423_w crossref_primary_10_1007_s40263_018_0530_8 crossref_primary_10_1177_1352458518807076 crossref_primary_10_3390_jcm11237003 crossref_primary_10_1016_j_acra_2024_08_048 crossref_primary_10_1177_1357633X211054839 crossref_primary_10_1016_j_msard_2020_102343 crossref_primary_10_1002_mus_27036 crossref_primary_10_1016_j_msard_2022_104478 crossref_primary_10_1177_13524585231216007 crossref_primary_10_1016_j_nrleng_2020_04_028 crossref_primary_10_1016_j_msard_2022_103943 crossref_primary_10_1177_2055217320934835 crossref_primary_10_3390_ijerph191610080 crossref_primary_10_1016_j_msard_2024_105806 crossref_primary_10_1016_j_msard_2022_103942 crossref_primary_10_1177_1352458517729465 crossref_primary_10_1016_j_msard_2019_101508 crossref_primary_10_1016_j_physio_2020_07_006 crossref_primary_10_1080_01616412_2025_2484426 crossref_primary_10_1016_j_conctc_2024_101279 crossref_primary_10_1177_1352458519881991 crossref_primary_10_1177_20552076231205284 crossref_primary_10_1177_1352458518808194 crossref_primary_10_1016_j_msard_2022_103817 crossref_primary_10_3389_fneur_2023_1212113 crossref_primary_10_1016_j_heliyon_2022_e10259 crossref_primary_10_1089_g4h_2022_0112 crossref_primary_10_1155_2018_3273246 crossref_primary_10_1186_s13063_024_08425_x crossref_primary_10_3389_fneur_2017_00433 crossref_primary_10_1016_j_msard_2023_104521 crossref_primary_10_1016_j_msard_2022_104461 crossref_primary_10_1016_S1474_4422_20_30277_5 crossref_primary_10_1016_j_apmr_2025_02_005 crossref_primary_10_1016_j_msard_2024_105598 crossref_primary_10_1111_ene_15920 crossref_primary_10_1177_13524585251364766 crossref_primary_10_1088_1361_6579_ab8771 crossref_primary_10_3389_fresc_2023_1053577 crossref_primary_10_1016_j_neuroimage_2018_09_080 crossref_primary_10_1016_j_bspc_2024_106128 crossref_primary_10_1177_13524585241275013 crossref_primary_10_1007_s40141_023_00428_0 crossref_primary_10_1007_s10072_023_06770_4 crossref_primary_10_1016_j_jpsychires_2022_12_003 crossref_primary_10_2147_PPA_S509525 crossref_primary_10_7705_biomedica_6873 crossref_primary_10_1016_j_clinph_2019_11_024 crossref_primary_10_1111_ene_14162 crossref_primary_10_1177_1352458518808189 crossref_primary_10_1016_j_physio_2021_04_004 crossref_primary_10_3389_fneur_2025_1547573 crossref_primary_10_1016_j_msard_2019_01_043 crossref_primary_10_3389_fneur_2023_1243857 crossref_primary_10_3390_brainsci14040407 crossref_primary_10_2147_PPA_S411069 crossref_primary_10_1177_13524585221125372 crossref_primary_10_1016_j_nicl_2021_102705 crossref_primary_10_1186_s40673_020_00123_z crossref_primary_10_1016_j_msard_2024_106235 crossref_primary_10_1016_j_msard_2022_103644 crossref_primary_10_1016_j_urology_2025_01_074 crossref_primary_10_1109_TNSRE_2018_2846814 crossref_primary_10_17116_jnevro202412406136 crossref_primary_10_3233_RNN_201033 crossref_primary_10_1177_1352458518796690 crossref_primary_10_1155_2024_4882755 crossref_primary_10_1177_13524585241301854 crossref_primary_10_1177_1352458520960374 crossref_primary_10_1177_1352458520968797 crossref_primary_10_21020_husbfd_1375424 crossref_primary_10_1212_WNL_0000000000011863 crossref_primary_10_1016_j_msard_2024_105810 crossref_primary_10_2196_32453 crossref_primary_10_1007_s13311_022_01246_3 crossref_primary_10_2196_30394 crossref_primary_10_1177_13524585241273054 crossref_primary_10_1016_j_msard_2024_105938 crossref_primary_10_1177_13524585231185048 crossref_primary_10_3390_geriatrics8020031 crossref_primary_10_1038_s41582_020_00448_7 crossref_primary_10_1177_1352458518809294 crossref_primary_10_3390_ijerph20054287 crossref_primary_10_1016_j_ridd_2024_104670 crossref_primary_10_1177_15459683251318246 crossref_primary_10_1016_j_msard_2020_102422 crossref_primary_10_1038_s41598_024_67769_1 crossref_primary_10_1007_s11517_021_02467_y crossref_primary_10_3389_fnins_2023_1180454 crossref_primary_10_1007_s00415_024_12507_w crossref_primary_10_1186_s12984_025_01681_1 crossref_primary_10_7554_eLife_60090 crossref_primary_10_3389_fneur_2019_01395 crossref_primary_10_1177_20552076241228928 crossref_primary_10_29328_journal_jsmt_1001061 crossref_primary_10_1155_2021_5588335 crossref_primary_10_1017_cjn_2020_66 crossref_primary_10_1080_19390211_2024_2449030 crossref_primary_10_3389_fneur_2025_1563041 crossref_primary_10_1038_s41467_025_62156_4 crossref_primary_10_1177_13524585251335213 crossref_primary_10_1002_ejsc_12166 crossref_primary_10_1016_j_msard_2021_102977 crossref_primary_10_1177_13524585241259650 crossref_primary_10_1002_brb3_3635 crossref_primary_10_3389_fnhum_2024_1449388 crossref_primary_10_3389_fneur_2022_962535 crossref_primary_10_3390_medicina59010029 crossref_primary_10_7717_peerj_6037 crossref_primary_10_1016_j_clinbiomech_2017_11_010 crossref_primary_10_1080_23279095_2021_1962881 crossref_primary_10_2147_DNND_S384038 crossref_primary_10_1002_mus_27425 crossref_primary_10_1002_acn3_51928 crossref_primary_10_1002_mds_29661 crossref_primary_10_1212_CON_0000000000000727 crossref_primary_10_1177_13524585211063623 crossref_primary_10_3390_brainsci11040472 crossref_primary_10_7224_1537_2073_2019_083 crossref_primary_10_1007_s10072_025_08058_1 crossref_primary_10_1016_j_msard_2023_105414 crossref_primary_10_1016_j_msard_2023_104568 crossref_primary_10_1016_j_msard_2023_104561 crossref_primary_10_14326_abe_12_81 crossref_primary_10_3390_biomedicines12102277 crossref_primary_10_1186_s12883_024_03964_x crossref_primary_10_1002_jmri_29666 crossref_primary_10_1016_j_jpsychores_2023_111473 crossref_primary_10_2196_19598 crossref_primary_10_1007_s00701_019_04086_x crossref_primary_10_1111_ene_15560 crossref_primary_10_3390_jcm11123261 crossref_primary_10_1002_acn3_52224 crossref_primary_10_1016_j_msard_2024_105836 crossref_primary_10_1155_oti_8410494 crossref_primary_10_1177_03080226211008710 crossref_primary_10_1016_j_msard_2025_106661 crossref_primary_10_1111_1744_9987_14079 crossref_primary_10_3390_healthcare10101869 crossref_primary_10_1177_1352458520983584 crossref_primary_10_1016_j_msard_2024_106240 crossref_primary_10_3390_biomedicines10071729 crossref_primary_10_1007_s00415_024_12395_0 crossref_primary_10_1016_j_msard_2022_103683 crossref_primary_10_1136_bmjopen_2024_085241 crossref_primary_10_1177_1756286418803248 crossref_primary_10_1111_ene_14403 crossref_primary_10_1186_s12883_023_03513_y crossref_primary_10_1016_j_msard_2024_105863 crossref_primary_10_1016_j_msard_2025_106677 crossref_primary_10_3389_fneur_2020_00735 crossref_primary_10_1002_acn3_51705 crossref_primary_10_1177_20552173231169475 crossref_primary_10_1007_s00415_022_11171_2 crossref_primary_10_3389_fneur_2018_00905 crossref_primary_10_1016_j_ncl_2023_07_002 crossref_primary_10_3389_fneur_2024_1308498 crossref_primary_10_1002_acn3_70101 crossref_primary_10_1016_j_braindev_2025_104381 crossref_primary_10_1016_j_msard_2024_105749 crossref_primary_10_1177_13524585241310139 crossref_primary_10_1016_j_jocn_2025_111215 crossref_primary_10_1007_s40259_020_00435_w crossref_primary_10_1177_17562864251321696 crossref_primary_10_1186_s12883_020_01765_6 crossref_primary_10_2196_46521 crossref_primary_10_3390_life13071501 crossref_primary_10_3390_medicina57020104 crossref_primary_10_3390_ijms25031592 crossref_primary_10_1007_s13760_024_02609_7 crossref_primary_10_1177_13524585231189671 crossref_primary_10_1016_j_msard_2025_106674 crossref_primary_10_1016_j_msard_2025_106672 crossref_primary_10_1007_s00221_025_07044_5 crossref_primary_10_1007_s40120_025_00804_z crossref_primary_10_1080_07853890_2023_2166979 crossref_primary_10_1016_j_apmr_2025_08_017 crossref_primary_10_1007_s00415_018_9075_5 crossref_primary_10_1016_j_msard_2022_104094 crossref_primary_10_1136_bmjopen_2020_043699 crossref_primary_10_1155_2018_7425858 crossref_primary_10_7224_1537_2073_2020_114 crossref_primary_10_1016_j_msard_2023_104944 crossref_primary_10_1007_s00415_022_11306_5 crossref_primary_10_1016_j_measurement_2020_108304 crossref_primary_10_3390_mti3010006 crossref_primary_10_19161_etd_1604450 crossref_primary_10_1007_s12311_025_01885_0 crossref_primary_10_3390_brainsci12010063 crossref_primary_10_1007_s00415_025_13066_4 crossref_primary_10_1016_j_msard_2020_102067 crossref_primary_10_3390_brainsci15060644 crossref_primary_10_1016_j_apmr_2024_08_024 crossref_primary_10_1177_2055217320964940 crossref_primary_10_1186_s12984_020_00771_6 crossref_primary_10_1111_ene_14427 crossref_primary_10_3390_asi5010002 crossref_primary_10_1097_WCO_0000000000000928 crossref_primary_10_3390_jcm12093222 crossref_primary_10_1038_s41598_017_18066_7 crossref_primary_10_3390_brainsci11030384 crossref_primary_10_2196_63090 crossref_primary_10_1007_s00415_023_11945_2 crossref_primary_10_1177_15459683241298260 crossref_primary_10_1177_1758998319861402 crossref_primary_10_1016_j_msard_2021_102808 crossref_primary_10_3389_fimmu_2021_748357 crossref_primary_10_1016_S1474_4422_18_30069_3 crossref_primary_10_1016_j_smhl_2023_100402 crossref_primary_10_1038_s41598_024_62726_4 crossref_primary_10_1093_braincomms_fcaf215 crossref_primary_10_1016_j_heliyon_2024_e35834 crossref_primary_10_1007_s40273_020_00889_4 crossref_primary_10_1212_WNL_0000000000011123 crossref_primary_10_1016_j_msard_2024_105630 crossref_primary_10_17826_cumj_631595 crossref_primary_10_3390_pharmacy8020061 crossref_primary_10_1007_s00415_021_10674_8 crossref_primary_10_3390_neurolint14020035 crossref_primary_10_1016_j_msard_2021_102946 crossref_primary_10_1038_s41598_022_19952_5 crossref_primary_10_1080_09638288_2017_1336647 crossref_primary_10_3390_jpm14070692 crossref_primary_10_1186_s13063_020_04650_2 crossref_primary_10_1148_radiol_212510 crossref_primary_10_1212_WNL_0000000000012690 crossref_primary_10_1109_JBHI_2023_3272117 crossref_primary_10_1007_s00429_020_02143_1 crossref_primary_10_1186_s40648_023_00239_x crossref_primary_10_1186_s12909_025_07783_7 crossref_primary_10_1212_WNL_0000000000008519 crossref_primary_10_3389_fneur_2022_907245 crossref_primary_10_3390_biomedicines7030056 crossref_primary_10_1016_j_jht_2021_06_005 crossref_primary_10_1055_s_0040_1714744 crossref_primary_10_1007_s00415_021_10750_z |
| ContentType | Journal Article |
| CorporateAuthor | Multiple Sclerosis Outcome Assessments Consortium |
| CorporateAuthor_xml | – name: Multiple Sclerosis Outcome Assessments Consortium |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/1352458517690824 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-0970 |
| ExternalDocumentID | 28206826 |
| Genre | Journal Article |
| GroupedDBID | --- -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACRPL ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADDLC ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADTBJ ADUCT ADUKL ADVBO ADYCS ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFUIA AFVCE AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHDMH AHHFK AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU CGR COF CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS ECM EIF EJD EMOBN F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HZ~ J8X K.F K.J K9- M0R M1P M4V N9A NPM O9- P.B P2P PHGZT PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH 7X8 AAPII ABIDT ABJZC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c598t-9e00cc4f741e519b554cdcd6799afd294b81301709c8e518a115fe36d092d0b42 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 381 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000399859300014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-0970 |
| IngestDate | Sun Sep 28 09:50:02 EDT 2025 Thu Apr 03 06:56:49 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | assessment Multiple sclerosis psychometric properties Nine-Hole Peg Test upper extremity performance outcomes |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c598t-9e00cc4f741e519b554cdcd6799afd294b81301709c8e518a115fe36d092d0b42 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/1352458517690824 |
| PMID | 28206826 |
| PQID | 1869097090 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1869097090 pubmed_primary_28206826 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-01 |
| PublicationDateYYYYMMDD | 2017-04-01 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Multiple sclerosis |
| PublicationTitleAlternate | Mult Scler |
| PublicationYear | 2017 |
| References | 28206813 - Mult Scler. 2017 Apr;23(5):626-627 |
| References_xml | – reference: 28206813 - Mult Scler. 2017 Apr;23(5):626-627 |
| SSID | ssj0007735 |
| Score | 2.6371198 |
| SecondaryResourceType | review_article |
| Snippet | Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease.... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 711 |
| SubjectTerms | Activities of Daily Living Adult Disability Evaluation Female Humans Male Middle Aged Multiple Sclerosis - physiopathology Outcome Assessment (Health Care) Task Performance and Analysis Upper Extremity - physiopathology |
| Title | The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28206826 https://www.proquest.com/docview/1869097090 |
| Volume | 23 |
| WOSCitedRecordID | wos000399859300014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC6NEk3-ziJiKWXhh4q9ha2-5CCTVpT_f3OblJyEgQvYQlZdjNMZr6dmcyH0EOSKkYFE4RRbQmNHSVCuNQDOSOdLztUIpBN8CwT06kcNwG3qimr3NjEYKhNqX2MvBeokySPZPS4XBHPGuWzqw2Fxjbq9AHKeK3m07ZbOOeBYDOmnBM_t01T9mIAHtSnxDjzpN_0d4AZHM3g8L9bPEIHDcTET7VOHKMtW5ygvVGTRD9Fb6AaOIMhGZYfFo_tO57AIlhVWOGF8j1KsQk2GxA6XrZ_FuBFHVDEcANvKhFxBYuAq51XZ-h18DJ5HpKGX4HoVIo1kTaKtKYOQIUFIDcDZKGNNoxLqZxJJJ0J8HAxvJAW8IBQgB6d7TMTycREM5qco52iLOwlwtayNFYxHE5kRGPtCYmsARusFSBK5mgX3W9EloP--qSEKmz5VeWt0LroopZ7vqwbbeSJby4P55-rP8y-RvuJ97ihqOYGdRx8vfYW7erv9bz6vAuKAddsPPoBui3BgA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Nine-Hole+Peg+Test+as+a+manual+dexterity+performance+measure+for+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Feys%2C+Peter&rft.au=Lamers%2C+Ilse&rft.au=Francis%2C+Gordon&rft.au=Benedict%2C+Ralph&rft.date=2017-04-01&rft.issn=1477-0970&rft.eissn=1477-0970&rft.volume=23&rft.issue=5&rft.spage=711&rft_id=info:doi/10.1177%2F1352458517690824&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0970&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0970&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0970&client=summon |